Study Pilot of Phase II safety and efficacy for the prevention of the reinfection and the premature treatment of the recidiva from HCV in the patient subordinate to liver transplant

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-004574-25-IT

Enrollment

Registered

2006-02-06

Start date

2005-09-22

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients subordinates to transplant of liver for chronic hepetopathy HCV-related prevenction of the reinfection and premature treatment of the recidiva from HCV . MedDRA version: 6.1 Level: PT Classification code 10019744

Interventions

Trade Name: ALFAFERONE INIET.1F3000000UI Pharmaceutical Form: Solution for injection INN or Proposed INN: Interferon alfa natural Concentration unit: IU international unit(s) Concentration type: equal

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026